ArticleFrontiers in pharmacology2025

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS).

Xiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.